Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice
Open Access
- 1 January 2005
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 86 (1), 211-215
- https://doi.org/10.1099/vir.0.80530-0
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) has been identified as the aetiological agent of SARS. Thus, vaccination against SARS-CoV may represent an effective approach towards controlling SARS. The nucleocapsid (N) protein is thought to play a role in induction of cell-mediated immunity to SARS-CoV and thus it is important to characterize this protein. In the present study, an E1/partially E3-deleted, replication-defective human adenovirus 5 (Ad5) vector (Ad5-N-V) expressing the SARS-CoV N protein was constructed. The N protein, expressed in vitro by Ad5-N-V, was of the expected molecular mass of 50 kDa and was phosphorylated. Vaccination of C57BL/6 mice with Ad5-N-V generated potent SARS-CoV-specific humoral and T cell-mediated immune responses. These results show that Ad5-N-V may potentially be used as a SARS-CoV vaccine.Keywords
This publication has 24 references indexed in Scilit:
- Severe Acute Respiratory SyndromeClinical Infectious Diseases, 2004
- Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2004
- Antibody detection of SARS-CoV spike and nucleocapsid proteinBiochemical and Biophysical Research Communications, 2004
- Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid proteinBiochemical and Biophysical Research Communications, 2003
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Nucleocapsid-Independent Specific Viral RNA Packaging via Viral Envelope Protein and Viral RNA SignalJournal of Virology, 2003
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid proteinVirology, 1990